These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11294736)

  • 1. Emerging mechanisms of fluoroquinolone resistance.
    Hooper DC
    Emerg Infect Dis; 2001; 7(2):337-41. PubMed ID: 11294736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.
    Pan XS; Fisher LM
    J Bacteriol; 1996 Jul; 178(14):4060-9. PubMed ID: 8763932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae.
    Widdowson CA; Klugman KP
    Semin Respir Infect; 1999 Sep; 14(3):255-68. PubMed ID: 10501313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants.
    Croisier D; Etienne M; Piroth L; Bergoin E; Lequeu C; Portier H; Chavanet P
    J Antimicrob Chemother; 2004 Sep; 54(3):640-7. PubMed ID: 15317743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of fluoroquinolone resistance: an update 1994-1998.
    Piddock LJ
    Drugs; 1999; 58 Suppl 2():11-8. PubMed ID: 10553699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of resistance to fluoroquinolones: state-of-the-art 1992-1994.
    Piddock LJ
    Drugs; 1995; 49 Suppl 2():29-35. PubMed ID: 8549336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae.
    Johnson CN; Briles DE; Benjamin WH; Hollingshead SK; Waites KB
    Emerg Infect Dis; 2005 Jun; 11(6):814-20. PubMed ID: 15963274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae.
    Richardson DC; Bast D; McGeer A; Low DE
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1911-4. PubMed ID: 11353652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms for the development of quinolone resistance].
    Kojima M
    Nihon Rinsho; 1997 May; 55(5):1252-60. PubMed ID: 9155183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
    Weigel LM; Anderson GJ; Facklam RR; Tenover FC
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3517-23. PubMed ID: 11709333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of action and resistance of older and newer fluoroquinolones.
    Hooper DC
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S24-8. PubMed ID: 10984324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of gemifloxacin against invasive and multi-resistant Streptococcus pneumoniae isolates collected in the UK.
    Johnson AP; Warner M; Nguyen-Van-Tam JS; Livermore DM
    J Antimicrob Chemother; 2003 Jan; 51(1):188-90. PubMed ID: 12493813
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
    Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug treatment of pneumococcal pneumonia in the elderly.
    Neralla S; Meyer KC
    Drugs Aging; 2004; 21(13):851-64. PubMed ID: 15493950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones.
    Pestova E; Millichap JJ; Noskin GA; Peterson LR
    J Antimicrob Chemother; 2000 May; 45(5):583-90. PubMed ID: 10797078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone resistance in Streptococcus pneumoniae: evidence that gyrA mutations arise at a lower rate and that mutation in gyrA or parC predisposes to further mutation.
    Gillespie SH; Voelker LL; Ambler JE; Traini C; Dickens A
    Microb Drug Resist; 2003; 9(1):17-24. PubMed ID: 12705679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone resistance among Gram-positive cocci.
    Hooper DC
    Lancet Infect Dis; 2002 Sep; 2(9):530-8. PubMed ID: 12206969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of fluoroquinolones against gram-positive bacteria.
    Bush K; Goldschmidt R
    Curr Opin Investig Drugs; 2000 Sep; 1(1):22-30. PubMed ID: 11249591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of fluoroquinolone resistant strains and resistance precursor strains in Streptococcus pneumoniae from patients with community-acquired pneumonia despite high fluoroquinolone usage.
    Pletz MW; van der Linden M; von Baum H; Duesberg CB; Klugman KP; Welte T;
    Int J Med Microbiol; 2011 Jan; 301(1):53-7. PubMed ID: 20692869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of fluoroquinolone resistance.
    Chen FJ; Lo HJ
    J Microbiol Immunol Infect; 2003 Mar; 36(1):1-9. PubMed ID: 12741725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.